Keratin 6B inhibitors constitute a class of chemical compounds designed to target and interfere with the activity of Keratin 6B, a specific member of the keratin protein family. Keratins are structural proteins that play pivotal roles in maintaining the integrity of epithelial tissues, such as skin, hair, and nails. Keratin 6B, although less studied than some other keratins, is believed to contribute to the structural stability of epithelial cells and their ability to withstand mechanical stress and maintain tissue integrity.
The primary mechanism of action for Keratin 6B inhibitors typically involves their interaction with the Keratin 6B protein or its associated molecules, leading to the disruption of its normal structural and functional properties. By inhibiting Keratin 6B, these compounds have the potential to impact the organization and mechanical properties of epithelial cells where it is expressed. Researchers studying Keratin 6B inhibitors aim to elucidate the specific roles and functions of Keratin 6B in cellular biology, contributing to our understanding of its significance within the context of tissue integrity and mechanical resilience. These inhibitors serve as valuable tools for advancing our knowledge of keratin biology and the contributions of specific keratin isoforms to the structural properties of various epithelial tissues. In this context, they contribute to expanding our understanding of the complex world of cytoskeletal proteins and their roles in maintaining tissue integrity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Sirolimus binds to mTOR and inhibits its pathway, which could downregulate protein synthesis, including that of K6B. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin binds to Hsp90 and inhibits its function, potentially affecting protein folding and degradation systems that could involve K6B. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor which may downregulate cell proliferation and subsequently K6B expression. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK1/2, which may lead to reduced MAPK pathway signaling and could decrease K6B expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which may affect transcription factors and potentially lower K6B expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, which could modulate inflammatory response and indirectly affect K6B expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an MEK inhibitor that could lead to reduced ERK pathway activity, potentially decreasing K6B expression. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor, which may affect a range of signaling pathways and potentially downregulate K6B expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin modulates various cell signaling pathways and could potentially reduce K6B expression in epithelial cells. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane may affect the NRF2 pathway and thus could influence the expression of certain keratins, including K6B. | ||||||